FABRY DISEASE TREATMENT MARKET ANALYSIS

Fabry Disease Treatment Market, by Drugs (Approved Drugs ((Agalsidase Beta (Fabrazyme/Replagal), and Migalastat (Galafold)), and Pipeline Drugs), by Molecule Type (Small Molecule and Large Molecule (Biologics)), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2326
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Fabry Disease Treatment Market Key Players

Key players operating in global Fabry disease treatment market include: Amicus Therapeutics Inc., Sanofi Genzyme (Sanofi S.A. company), Idorsia Pharmaceuticals Ltd., Protalix BioTherapeutics, Inc., AvroBio Inc., JCR Pharmaceuticals Co., Ltd., Resverlogix Corp, and Ozmosis Research Inc.